Carriers of pathogenic BRCA2 variants have a lifetime risk of developing breast cancer ranging from 38% to 84%, while the risk of developing ovarian cancer ranges from 16.5% to 27.0% [8, 9]. Here, BRCA2 is linked to breast carcinoma.